Results 121 to 130 of about 1,208,573 (299)
[Efficacy of metformin in abdominal obesity].
To study the effect of metformin on metabolic parameters, body weight (BW), and waist circumference (WC) in patients with abdominal obesity (AO).The results of using metformin 2000 mg daily for 3 months in 46 patients with AO. The comparison group consisted of 50 people.
A M Mkrtumian +4 more
openaire +2 more sources
Changes in the Prevalences of Obesity, Abdominal Obesity, and Non-Alcoholic Fatty Liver Disease among Korean Children during the COVID-19 Outbreak. [PDF]
Song K +8 more
europepmc +1 more source
Aims This study aimed to evaluate the safety, tolerability and pharmacokinetics of a novel oral modified‐release psilocybin formulation (REL‐P11) in normal‐weight and overweight/obese healthy adults and to assess its suitability for controlled, subperceptual exposure, in light of emerging evidence supporting serotonergic modulation in metabolic ...
Anna Signor +11 more
wiley +1 more source
The prevalence of general obesity, abdominal obesity, and hypertension and its related risk factors among young adult students in Bangladesh. [PDF]
Ali N +6 more
europepmc +1 more source
Aims Elecoglipron (AZD5004/ECC5004) is an oral small‐molecule glucagon‐like peptide‐1 receptor agonist (GLP‐1 RA) in development for weight management in people living with obesity or overweight and type 2 diabetes. This study aimed to characterize the pharmacokinetics (PK) profiles of two formulations of elecoglipron under fed and fasted conditions ...
Jianfeng Xu +13 more
wiley +1 more source
Obesity, a chronic state of energy overload, is characterized by adipose tissue dysfunction that is considered to be the major driver for obesity associated metabolic complications.
Riikka Jokinen +3 more
doaj +1 more source
Introduction The rapid uptake of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) for obesity has been accompanied by increasing use outside approved indications and medical supervision. Evidence regarding the harms associated with such misuse remains limited because these situations are not captured in clinical trials and are difficult to ...
Jean‐Luc Faillie
wiley +1 more source
Criteria for EASO-Collaborating Centres for Obesity Management
Obesity is recognised as a global epidemic and the most prevalent metabolic disease world-wide. Specialised obesity services, however, are not widely available in Europe, and obesity care can vary enormously across European regions.
Hermann Toplak +35 more
core +1 more source
Background. Links between dietary quality and abdominal obesity are poorly understood. Objective. To examine the association between an obesity-specific dietary quality index and abdominal obesity risk in women. Methods.
Dolores M. Wolongevicz +6 more
doaj +1 more source
Obesity, Abdominal Obesity and Chronic Kidney Disease in Young Adults: A Nationwide Population-Based Cohort Study. [PDF]
Bae EH +8 more
europepmc +1 more source

